Genome-wide interaction study of brain beta-amyloid burden and cognitive impairment in Alzheimer’s disease
Aristotle N. Voineskos(Centre for Addiction and Mental Health), Bruce G. Pollock(University of Pittsburgh), David A. Bennett(Rush University Medical Center), Arash Nazeri, Tina Roostaei(Columbia University Irving Medical Center), Philip L. De Jager(Broad Institute), Daniel Felsky(Centre for Addiction and Mental Health), Julie A. Schneider(Rush University Medical Center)
Cited by 71
Related Papers
National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
|Alzheimer s & Dementia|2012|3.2k
National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
|Acta Neuropathologica|2011|2.9k
Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature
|Journal of Neuropathology & Experimental Neurology|2012|2.1k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Primary age-related tauopathy (PART): a common pathology associated with human aging
|Acta Neuropathologica|2014|1.5k